The acquisition expands Merit’s portfolio of therapeutic oncology products dedicated to the accurate diagnosis and localization of breast and soft tissue tumors.

LONDON--(BUSINESS WIRE)--Global breast biopsy devices market will grow by USD 504.94 million during 2020-2024. Amid the COVID-19 pandemic the global breast biopsy devices market registered a YOY ...

A new device is making it easier to locate small tumors in the breast, and that's not the only benefit, according to Women & Infants hospital breast surgeon Dr. David Edmonson. One of Edmonson's ...

View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.

Rising incidence of breast cancer, growing adoption of breast-conserving surgeries, and increasing demand for minimally invasive and radiation-free localization technologies are the major factors ...

Hologic, Inc. HOLX announced an extension of its LOCalizer radiofrequency identification (“RFID”) tag’s CE Mark. Under the extended approval, the tag can now be implanted more than 30 days prior to ...

DUBLIN--(BUSINESS WIRE)--The "Breast Imaging Device Market Size, Outlook and Growth Opportunities, 2019- 2025" report has been added to ResearchAndMarkets.com's offering. The 'Breast Imaging Device ...

Newark, NJ, July 23, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global breast lesion localization market is expected to grow from USD 280 million in 2019 to USD 416.85 ...

Reviewed by Eleonora Teplinsky, MD, Head of Breast Medical Oncology at Valley Health System in Paramus, New Jersey, Clinical Assistant Professor at Icahn School of Medicine at Mount Sinai in New York ...